| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/12/2012 | US20120087923 Antibodies to OPGL |
| 04/12/2012 | US20120087922 Dr5 antibodies and uses thereof |
| 04/12/2012 | US20120087921 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer |
| 04/12/2012 | US20120087920 Fgf21 mutants and uses thereof |
| 04/12/2012 | US20120087919 Method for treating diabetes |
| 04/12/2012 | US20120087918 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 04/12/2012 | US20120087917 Lox and loxl2 inhibitors and uses thereof |
| 04/12/2012 | US20120087916 Anti-icam-1 antibody, uses and methods |
| 04/12/2012 | US20120087915 Use of inhibitors of bruton's tyrosine kinase (btk) |
| 04/12/2012 | US20120087914 Inhibition of trim62 activity reduces cancer cell proliferation |
| 04/12/2012 | US20120087913 Induction of tumor hypoxia for cancer therapy |
| 04/12/2012 | US20120087912 Treatment methods using dkk-1 antibodies |
| 04/12/2012 | US20120087911 Crystal structure |
| 04/12/2012 | US20120087910 Sparc angiogenic domain and methods of use |
| 04/12/2012 | US20120087909 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 04/12/2012 | US20120087893 Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent |
| 04/12/2012 | US20120087891 Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances |
| 04/12/2012 | US20120087890 IMMUNONANOTHERAPEUTICS THAT PROVIDE IgG HUMORAL RESPONSE WITHOUT T-CELL ANTIGEN |
| 04/12/2012 | US20120087870 Novel caviidae allergens and uses thereof |
| 04/12/2012 | US20120087861 Human Anti-Tau Antibodies |
| 04/12/2012 | US20120087859 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties |
| 04/12/2012 | US20120087858 Dual variable domain immunoglobulins and uses thereof |
| 04/12/2012 | CA2819010A1 Method to inhibit recruitment of monocytes and macrophages by an icam-3 inhibitor |
| 04/12/2012 | CA2814040A1 A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use |
| 04/12/2012 | CA2814030A1 Diagnostic and therapeutic uses of moesin fragments |
| 04/12/2012 | CA2814024A1 Moesin modulators and uses thereof |
| 04/12/2012 | CA2813900A1 Methods of treating psoriasis using il-17 antagonists |
| 04/12/2012 | CA2813814A1 Tumor specific antibodies and uses therefor |
| 04/12/2012 | CA2813738A1 Mutant smoothened and methods of using the same |
| 04/12/2012 | CA2813612A1 Methods and compositions using anti-lps ligands for the treatment and prevention of inflammatory disorders |
| 04/12/2012 | CA2813587A1 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
| 04/12/2012 | CA2813488A1 Composition for intraocular implantation of bevacizumab |
| 04/12/2012 | CA2813208A1 Methods for treating psoriasis |
| 04/12/2012 | CA2813146A1 Oral vaccine fast-dissolving dosage form using starch |
| 04/12/2012 | CA2813080A1 Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer |
| 04/12/2012 | CA2813078A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 04/12/2012 | CA2812865A1 Phosphospecific antibodies recognising tau |
| 04/12/2012 | CA2812795A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases |
| 04/12/2012 | CA2812731A1 Clostridium difficile antigens |
| 04/12/2012 | CA2811644A1 Antibody drug conjugates (adc) that bind to 191p4d12 proteins |
| 04/12/2012 | CA2811087A1 Antibody compositions and methods of use |
| 04/12/2012 | CA2809925A1 Cd33 binding agents |
| 04/11/2012 | EP2439213A1 Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof |
| 04/11/2012 | EP2439210A1 Ehrlichia Canis DIVA (Differentiation of Infected from Vaccinated Animals) |
| 04/11/2012 | EP2438926A1 Vaccine for mycoplasma infection |
| 04/11/2012 | EP2438198A1 Compositions and methods for administration of vaccines against dengue virus |
| 04/11/2012 | EP2438090A1 Amino acid sequences which enhance peptide conjugate solubility |
| 04/11/2012 | EP2438089A1 TREATMENT OF ONCOSTATIN M RECEPTOR ß MEDIATED HEART FAILURE |
| 04/11/2012 | EP2438088A1 Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine -origin influenza a (h1n1) virus (s-oiv) infections |
| 04/11/2012 | EP2438082A1 Recombinantly produced allergens |
| 04/11/2012 | EP2437791A2 Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (iro) antagonists of tlr7 and tlr9 |
| 04/11/2012 | EP2437790A1 Conjugation methods |
| 04/11/2012 | EP2437780A1 Therapeutic compositions and methods for the prevention of autoimmune diseases |
| 04/11/2012 | EP2437779A1 Reagents and methods for detecting influenza virus proteins |
| 04/11/2012 | EP2437778A2 Recombinant subunit west nile virus vaccine for protections of human subjects |
| 04/11/2012 | EP2437777A1 COMBINATIONS OF PNEUMOCOCCAL RrgB CLADES |
| 04/11/2012 | EP2025749B1 Humanized anti-human osteopontin antibody |
| 04/11/2012 | EP1979001B1 Binding proteins specific for insulin-like growth factors and uses thereof |
| 04/11/2012 | EP1968632B1 Improved influenza vaccine |
| 04/11/2012 | EP1930427B1 Squamous cell carcinoma antigen-derived peptide binding to hla-a24 molecule |
| 04/11/2012 | EP1861121B1 Hiv vaccine composition |
| 04/11/2012 | EP1835937B1 Compositions and methods for treating viral infection |
| 04/11/2012 | EP1763364B1 Methods and compositions comprising supramolecular constructs |
| 04/11/2012 | EP1718767B1 Compositions for treating breast and pancreatic cancer |
| 04/11/2012 | EP1703893B1 Novel anti-il 13 antibodies and uses thereof |
| 04/11/2012 | EP1631316B1 Targeted biocides |
| 04/11/2012 | EP1603936B1 Use of lectins to promote oligomerization of glycoproteins and antigenic molecules |
| 04/11/2012 | EP1594533B1 Antibody vaccine conjugates and uses therefor |
| 04/11/2012 | EP1592441B1 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof |
| 04/11/2012 | EP1587537B1 Injectable vaccines against multiple meningococcal serogroups |
| 04/11/2012 | EP1575517B1 Anti-ngf antibodies and methods using same |
| 04/11/2012 | EP1503794B1 Methods of treatement using ctla-4 antibodies |
| 04/11/2012 | EP1377596B1 Ttk in diagnosis and as a therapeutic target in cancer |
| 04/11/2012 | EP1294400B1 Vaccine against foot-and-mouth disease |
| 04/11/2012 | EP1282646B1 Human monoclonal antibodies to dendritic cells |
| 04/11/2012 | EP1125947B1 Human H37 protein and cDNA encoding the same |
| 04/11/2012 | CN1440296B Vaccine against foot-and-mouth disease |
| 04/11/2012 | CN102414223A 对IL12受体β亚基特异的治疗性抗体的组合物和方法 The compositions and methods of the IL12 receptor β subunit-specific therapeutic antibody |
| 04/11/2012 | CN102413839A 人源化抗cd19抗体制剂 Humanized anti-cd19 antibody preparation |
| 04/11/2012 | CN102413838A Pneumococcal vaccine and uses thereof |
| 04/11/2012 | CN102413837A 预防再激活的结核病tb疫苗 Tb prevent reactivation of tuberculosis vaccine |
| 04/11/2012 | CN102409063A 黄病毒ns1亚单位疫苗 Flavivirus ns1 subunit vaccine |
| 04/11/2012 | CN102409028A 肠道病毒71型单克隆抗体及其应用 Enterovirus 71 monoclonal antibody and its application |
| 04/11/2012 | CN102408483A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/11/2012 | CN102406948A Constructing method of recombinant DNA (deoxyribonucleic acid) nucleic acid vaccine of vibrio alginolyticus HSP70 |
| 04/11/2012 | CN102406937A Novel cytokine zalpha11 ligand |
| 04/11/2012 | CN102406936A Chicken infectious coryza inactivated vaccine adjuvant |
| 04/11/2012 | CN102406935A 一种动物疾病预防或治疗用品及其应用 An animal disease prevention or treatment of supplies and its application |
| 04/11/2012 | CN102406934A 一种鸡传染性鼻炎类脂灭活疫苗的制备方法 Preparation method of infectious coryza lipid inactivated vaccine |
| 04/11/2012 | CN102406933A Preparation method for measles attenuated live vaccine |
| 04/11/2012 | CN102406932A 用于治疗/预防流感病原体在物种间传播的疫苗的用途 For the treatment / prevention of influenza vaccines pathogen spread among species of use |
| 04/11/2012 | CN102406931A Pandemic influenza virus split vaccine |
| 04/11/2012 | CN102406930A Method for preparing seasonal influenza virus split vaccine |
| 04/11/2012 | CN102406929A 一种共表达分子佐剂加强型二价口蹄疫蛋白工程疫苗 A co-expression of molecular adjuvant enhanced protein engineering bivalent FMD vaccine |
| 04/11/2012 | CN102406928A Method for producing human diploid cell poliomyelitis inactivated vaccine |
| 04/11/2012 | CN102406927A Method for producing human diploid cell encephalitis B inactivated vaccine |
| 04/11/2012 | CN102406926A 一种聚酯类纤维载体培养细胞以制备病毒或生产疫苗的方法 A method of polyester fiber carrier cultured cells to produce virus or vaccine production |
| 04/11/2012 | CN102406925A 一种鸡传染性鼻炎、鸡毒支原体二联类脂灭活疫苗的制备方法 One kind of infectious coryza, Mycoplasma gallisepticum bivalent inactivated vaccine preparation lipid |
| 04/11/2012 | CN101678090B Compositions and methods for the prevention and treatment of autoimmune conditions |
| 04/11/2012 | CN101277976B 抗肌抑制素抗体 Anti-myostatin antibodies |